{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T04:02:12Z","timestamp":1770004932677,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.yrtph.2019.05.019","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T10:14:35Z","timestamp":1558174475000},"page":"292-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["REACH alternative testing strategy for skin sensitization in practice: Fact or fiction?"],"prefix":"10.1016","volume":"106","author":[{"given":"Helma M.","family":"Barentsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon U.","family":"Jonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia M.G.J.","family":"Pelgrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen C.W.","family":"Rijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter M.A.","family":"Westerink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette J.C.","family":"Paulussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2019.05.019_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/424203","article-title":"The LLNA: a brief review of recent advances and limitations","volume":"2011","author":"Anderson","year":"2011","journal-title":"J. Allergy"},{"key":"10.1016\/j.yrtph.2019.05.019_bib2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jat.3448","article-title":"A quantitative in silico model for predicting skin sensitization using a nearest neighbours approach within expert-derived structure-activity alert spaces","volume":"37","author":"Canipa","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.yrtph.2018.03.015","article-title":"Making reliable negative predictions of human skin sensitization using an in silico fragmentation approach","volume":"95","author":"Chilton","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tiv.2016.01.007","article-title":"SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: reproducibility and predictivity results from an inter-laboratory study","volume":"32","author":"Cottrez","year":"2016","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2019.05.019_bib5","series-title":"Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.7a: Endpoint Specific Guidance. Version 6.0, July 2017","author":"ECHA","year":"2017"},{"key":"10.1016\/j.yrtph.2019.05.019_bib6","series-title":"Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.7a: Endpoint Specific Guidance. Version 6.0, July 2017","author":"ECHA","year":"2017"},{"key":"10.1016\/j.yrtph.2019.05.019_bib8","article-title":"Regulation (EC) No 1272\/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labeling, and packaging of substances and mixtures","author":"EU","year":"2008","journal-title":"Official Journal of the European Union"},{"key":"10.1016\/j.yrtph.2019.05.019_bib9","series-title":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes, 20.10.2010, O.J. L 276","first-page":"33","author":"EU","year":"2010"},{"key":"10.1016\/j.yrtph.2019.05.019_bib10","first-page":"14","author":"EU Com","year":"2016"},{"key":"10.1016\/j.yrtph.2019.05.019_bib11","first-page":"8","author":"EU Com","year":"2017"},{"key":"10.1016\/j.yrtph.2019.05.019_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jat.3348","article-title":"What determines skin sensitization potency: myths, maybes and realities. The 500 molecular weight cut-off: an updated analysis","volume":"37","author":"Fitzpatrick","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jat.3354","article-title":"Is skin penetration a determining factor in skin sensitization potential and potency? Refuting the notion of a logKow threshold for skin sensitization","volume":"37","author":"Fitzpatrick","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.yrtph.2017.09.023","article-title":"In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds","volume":"90","author":"Kreiling","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib15","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.fct.2008.01.019","article-title":"Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the Guinea pig maximization test (GPMT)","volume":"46","author":"Kreiling","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib16","series-title":"Skin Sensitisation Assessment Using Derek Nexus","author":"Lhasa","year":"2019"},{"key":"10.1016\/j.yrtph.2019.05.019_bib17","series-title":"Skin Sensitisation. OECD Guideline for the Testing of Chemicals No 406","author":"OECD","year":"1992"},{"key":"10.1016\/j.yrtph.2019.05.019_bib18","series-title":"Skin Sensitisation: Local Lymph Node Assay, OECD Guideline for the Testing of Chemicals No 429","author":"OECD","year":"2010"},{"key":"10.1016\/j.yrtph.2019.05.019_bib19","series-title":"In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA). OECD Guideline for the Testing of Chemicals No 422C","author":"OECD","year":"2015"},{"key":"10.1016\/j.yrtph.2019.05.019_bib20","series-title":"In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method. OECD Guideline for the Testing of Chemicals No 422D","author":"OECD","year":"2015"},{"key":"10.1016\/j.yrtph.2019.05.019_bib21","author":"OECD","year":"2016"},{"key":"10.1016\/j.yrtph.2019.05.019_bib22","series-title":"Vitro Skin Sensitisation Assays Addressing the Key Event on Activation of Dendritic Cells on the Adverse Outcome Pathway for Skin Sensitisation. OECD Guideline for the Testing of Chemicals No 422E","article-title":"Skin sensitization","author":"OECD","year":"2017"},{"key":"10.1016\/j.yrtph.2019.05.019_bib23","series-title":"Vitro Skin Sensitisation Assays Addressing the AOP Key Event on Keratinocyte Activation. OECD Guideline for the Testing of Chemicals No 422D","article-title":"Key event based test guideline 442D","author":"OECD","year":"2018"},{"key":"10.1016\/j.yrtph.2019.05.019_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yrtph.2017.06.002","article-title":"Binary test battery with KeratinoSensTM and h-CLAT as part of a bottom-up approach for skin sensitization hazard prediction","volume":"88","author":"Otsubo","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jat.1289","article-title":"Determinants of skin sensitization potential","volume":"28","author":"Roberts","year":"2008","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jat.3479","article-title":"Non-animal assessment of skin sensitization hazard: is an integrated testing strategy needed, and if so what should be integrated?","volume":"38","author":"Roberts","year":"2017","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yrtph.2018.04.022","article-title":"Chemical applicability domain of the local lymph node assay (LLNA) for skin sensitization potency. Part 4. Quantitative correlation of LLNA potency with human potency","volume":"96","author":"Roberts","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.yrtph.2018.07.014","article-title":"Is a combination of assays really needed for non-animal prediction of skin sensitization potential? Performance of the GARDTM (Genonic Allergen Rapid Detection) assay in comparison with OECD guideline assays alone and in combination","volume":"98","author":"Roberts","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib29","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/jat.3127","article-title":"Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitization potential and potency of chemicals","volume":"35","author":"Takenouchi","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2019.05.019_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tiv.2016.04.005","article-title":"Peptide reactivity associated with skin sensitization: the QSAR Toolbox and TIMES compared to the DPRA","volume":"34","author":"Urbisch","year":"2016","journal-title":"Toxicol. Vitro"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019301473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019301473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T11:49:03Z","timestamp":1577188143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230019301473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":29,"alternative-id":["S0273230019301473"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.05.019","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"REACH alternative testing strategy for skin sensitization in practice: Fact or fiction?","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}